NCT00177086View on ClinicalTrials.gov

Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Kidney CalculiUreteral CalculiColic
Interventions
OTHER

Alfuzosin Hydrochloride

One tablet every day for 4 weeks

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Manoj, Monga, M.D.

INDIV

lead

University of Minnesota

OTHER

NCT00177086 - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi | Biotech Hunter | Biotech Hunter